ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

538 results

Operator volumes and in-hospital outcomes: an analysis of 7,740 rotational atherectomy procedures from the BCIS national database

05 Jul 2021

Find out more about the results of this analysis which suggest that operator experience may be an important effect modifier in ROTA-PCI.

Nicola Ryan

Reviewer

Nicola Ryan
Operator volumes and in-hospital outcomes: an analysis of 7,740 rotational atherectomy procedures from the BCIS national database

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

18 Jun 2021

The HOST-EXAM trial sought to define whether, after DAPT for PCI with DES, clopidogrel monotherapy is associated with improved outcomes compared with aspirin monotherapy.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Aspirin vs clopidogrel for chronic maintenance monotherapy after PCI: HOST-EXAM trial

EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!

27 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in imaging:

  • Angiography based Fractional Flow Reserve: the FAST II trial
  • Instantaneous wave-free ratio for the assessment of nonculprit lesions
  • Capacity of the PPG to predict functional revascularisation
  • Clinical impact of FFR guided PCI
EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!

EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!

27 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in imaging:

  • A randomized study comparing imaging guided implantation of Orsiro and Xience: the CASTLE study
  • Impact of different optimal stent implantation definitions in OCT-guide PCI
  • Risk-stratification in ACS by comprehensive morphofunctional assessment with OCT
  • 7.5 years follow-up after OCT-guided PCI: report...
EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction - FLOWER-MI

26 May 2021

This investigator-initiated randomised, open-label, multicentre trial compares FFR versus angiography guided strategies for treating non-culprit lesions in patients presenting with STEMI and multivessel coronary artery disease. The results of this study were released during ACC.21.

Nicola Ryan

Reviewer

Nicola Ryan
M. Pighi

Reviewer

Michele Pighi
Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction - FLOWER-MI

EuroPCR 2021 Hotlines / Late-Breaking Trials in ACS: COOL AMI EU pivotal rial and more!

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in ACS:

  • COOL AMI EU pivotal trial
  • Complete versus incomplete revascularization in NSTEMI patients
  • Non-hyperaemic IMRangio and long-term clinical outcome in STEMI
EuroPCR 2021 Hotlines / Late-Breaking Trials in ACS: COOL AMI EU pivotal rial and more!

EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in BRS/BVS:

  • Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
  • France Absorb registry: final five years follow-up
  • A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
  • Three-year follow-up of the prospective bvs stemi strategy-it study
  • Final five-year results of AIDA trial
  • Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in drugs & devices:

  • POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
  • CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
  • PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

Managing a patient with STEMI and bystander disease in the pandemic (Part 2) - Session with LIVE case

20 May 2021 – From EuroPCR 2021

Watch this session if you want to be updated on developments in treatment of ACS and STEMI, and to discuss diagnosis and treatment for bystander disease.

This session was originally presented during EuroPCR 2021.

Managing a patient with STEMI and bystander disease in the pandemic - Part 2

Managing a patient with STEMI and bystander disease in the pandemic (Part 1) - Session with LIVE demonstration

20 May 2021 – From EuroPCR 2021

Watch this session if you want to be updated on developments in treatment of ACS and STEMI and to discuss diagnosis and treatment for bystander disease.

This session was originally presented during EuroPCR 2021.

Managing a patient with STEMI and bystander disease in the pandemic - Part 1